Artia Global Partners »

Ascendis Pharma AS shares owned by Artia Global Partners

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7M 18k 266.72

More positions owned by Artia Global Partners

Abivax Sa Sponsored Ads (ABVX)
Insmed Com Par $.01 (INSM)
Trevi Therapeutics (TRVI)
Brightspring Health Svcs (BTSG)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Alkermes SHS (ALKS)
Travere Therapeutics (TVTX)
Astrazeneca Ord (AZN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Dianthus Therapeutics (DNTH)
Spdr Series Trust St Str Sp Biot (XBI)
Quest Diagnostics Incorporated (DGX)
Ionis Pharmaceuticals (IONS)
Eyepoint Com New (EYPT)

View all positions for Artia Global Partners

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS